Nancy C Reich (Nancy C Reich Marshall)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C Reich
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. eLife 13 (2024)
Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C Reich
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. eLife 13 (2024)
Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C Reich
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. eLife 13 (2024)
Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C Reich
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. eLife 13 (2024)
Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C Reich
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancer. bioRxiv : the preprint server for biology (2023)
Jinyu Li, Stephen D'Amico, Varvara Kirillov, Oleksi Petrenko, Nancy C Reich
Oncogenic dependency plays a dominant role in the immune response to cancer. Proceedings of the National Academy of Sciences of the United States of America 120 (41) (2023)
Nancy C Reich
Howard Young Commentary. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research (2022)
Irene Ischenko, Stephen D'Amico, Manisha Rao, Jinyu Li, Michael J Hayman, Scott Powers, Oleksi Petrenko, Nancy C Reich
KRAS drives immune evasion in a genetic model of pancreatic cancer. Nature communications 12 (1) (2021)
Oleksi Petrenko, Jinyu Li, Velasco Cimica, Patricio Mena-Taboada, Ha Youn Shin, Stephen D'Amico, Nancy C Reich
IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3. PloS one 16 (3) (2021)